IE40824B1 - New antibiotics - Google Patents

New antibiotics

Info

Publication number
IE40824B1
IE40824B1 IE534/75A IE53475A IE40824B1 IE 40824 B1 IE40824 B1 IE 40824B1 IE 534/75 A IE534/75 A IE 534/75A IE 53475 A IE53475 A IE 53475A IE 40824 B1 IE40824 B1 IE 40824B1
Authority
IE
Ireland
Prior art keywords
water
approxiamtely
accompanying drawings
absorption
butanol
Prior art date
Application number
IE534/75A
Other versions
IE40824L (en
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB13856/74A external-priority patent/GB1489235A/en
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of IE40824L publication Critical patent/IE40824L/en
Publication of IE40824B1 publication Critical patent/IE40824B1/en

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A process for the preparation of an antibacterially active carboxylic acid compound designated as MM 13902 and salts thereof, which substance MM 13902 is sold carbxylic acid characterised in that its pure di-sodium salt; (i) is highly soluble in water, soluble in methanol and substantially insolubel in chloroform, diethylether and hydro-carbons; (ii) in aqueous solution has an ultra-violet spectrum substnatially as shown in Fig. 1 of the accompanying drawings with absorption maxima at about 305 and 225 mm; (iii) when present at 0.4% w/w in a freshly prepared KBr disc has an infra-red absorption spectrum substantially as shown in Fig. 2, of the accompanying drawings with absorption maxima at inter alia about 3450, 2950, 1750, 1620, 1510, 1400 and 1260cm1; (iv) has an n.m.r. specturm substantially as shown in Fig. 3 of the accompanying drawings when taken in a freshly prepared solution in D2O with inter alia (a) a pair of low fiedl doubelts centred at approximately 2.85GAMMA and 4.00GAMMA with coupling constants of approxiamtely 14 Hz; (b) a doublet centered at approxiamtely 8.55 and (c0 a sharp signlet at approxiamtely 8.00; (v) has the following approxdiamte Rf values ethn run on a cellulose thiin layer chromatogrpahy system; (a) n_butanol/ isopropanol/ water-7:7:6 v/v; Rf=0.72 (b) isopropanol/water-7:3 v/v; Rf=0.85 (c) n-butanol/ethanol/water-7:7:6 v/v; Rf0.81 (d) n-propanol/water-4:1; Rf=0.75; (vi) has an I50 of between 0.001/ug/ml and 0.0001/ug/ml against the beta-lactamase of Escherichia coli B11; (vii) synergises the activity of ampicillin against organisms includign strains of Escherichia coli, Klebnsiella aerogenes, Proteus mirabills, Proteus morganii and Staphylococcus aureus Russell; which process comprises the aerobic grouth of a MM 13902 producing strain of Streptomyces in the presence of assimilable soruces of cabron, nitrogen, sulphur and mineral salts in a solid or semi-solid nutritive medium or in a liquid medium in which the nutrients are dissovled or supsended, at a temperature of 28+/-2degree C for 2 to 3 days and thereafter extracting the antibiotics opresent from the culture medium, either by initial absorption on to and then elution from active characoal or an ion-exchange resin cotnaining tertiary amino grous or quternary ammonium groups or by extracting into a solution of a lipophilic ammonium salt in a water immiscible soluvent at a temperature not exceeding 20degrees C and separatign the MM 13902 therefrom by column chromatograpohy either by using a cellulose or silica-gel column and eluting eith mixtures of water with water-miscible organic solvents or by using columns of ion-exchange resins containing tertiary amino grouups or quarternary ammonium groups and eluting with aqueous solutions of electrolytes buffered to appropriate neutrality. [IN141262A1]
IE534/75A 1974-03-28 1975-03-19 New antibiotics IE40824B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB13856/74A GB1489235A (en) 1974-03-28 1974-03-28 Antibiotics

Publications (2)

Publication Number Publication Date
IE40824L IE40824L (en) 1975-09-28
IE40824B1 true IE40824B1 (en) 1979-08-29

Family

ID=10030627

Family Applications (2)

Application Number Title Priority Date Filing Date
IE604/75A IE40864B1 (en) 1974-03-28 1975-03-19 Antibiotics
IE534/75A IE40824B1 (en) 1974-03-28 1975-03-19 New antibiotics

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IE604/75A IE40864B1 (en) 1974-03-28 1975-03-19 Antibiotics

Country Status (15)

Country Link
CS (1) CS199264B2 (en)
DD (1) DD116852A5 (en)
DK (1) DK140150B (en)
ES (1) ES436104A1 (en)
FI (1) FI55352C (en)
HU (1) HU170786B (en)
IE (2) IE40864B1 (en)
IL (1) IL46837A (en)
IN (1) IN141262B (en)
NO (1) NO144394C (en)
NZ (1) NZ176970A (en)
PL (1) PL94006B1 (en)
SU (1) SU528038A3 (en)
YU (1) YU79275A (en)
ZA (1) ZA751934B (en)

Also Published As

Publication number Publication date
DK140150C (en) 1979-11-26
NZ176970A (en) 1981-03-16
FI55352C (en) 1979-07-10
IL46837A0 (en) 1975-05-22
IN141262B (en) 1977-02-05
DK132875A (en) 1975-09-29
IE40864L (en) 1975-09-28
SU528038A3 (en) 1976-09-05
IE40824L (en) 1975-09-28
CS199264B2 (en) 1980-07-31
IL46837A (en) 1978-07-31
HU170786B (en) 1977-09-28
ES436104A1 (en) 1977-07-01
YU79275A (en) 1982-02-28
DD116852A5 (en) 1975-12-12
NO144394B (en) 1981-05-11
NO751075L (en) 1975-09-30
NO144394C (en) 1981-08-19
ZA751934B (en) 1976-04-28
FI750958A (en) 1975-09-29
IE40864B1 (en) 1979-08-29
DK140150B (en) 1979-06-25
FI55352B (en) 1979-03-30
PL94006B1 (en) 1977-07-30

Similar Documents

Publication Publication Date Title
Haneishi et al. Oxazinomycin, a New Carbon-Linked Nugleoside Antibiotic
GB1376983A (en) Enzyme stabilization
Ishibashi Studies on antibiotics from Helminthosporium sp. fungi. VII Siccanin, a new antifungal antibiotic produced by Helminthosporium siccans
US3207755A (en) Transformation products of cephalosporin c and derivatives thereof
IE36881L (en) 7, 7-disubstituted cepalosporins and 6, 6-disubstituted¹penicillins
US4261977A (en) Streptomycetal antibiotic
IE40824B1 (en) New antibiotics
GB1387212A (en) Turf maintenance machine
GB932898A (en) A process for the production of 5-nucleotides
US3733320A (en) Antibiotic purification processes
CA1153968A (en) Antibiotic pa-31088-iv and production thereof
IE37892B1 (en) Antibiotic a-2315 and process for preparation thereof
US3219662A (en) Transformation products of cephalosporin c and derivatives thereof
Yagishita Production of Phenazine Compounds by Stretomyces Griseoluteus
NL151436B (en) PROCESS FOR PREPARING AN ANTIBIOTIC BY A STREPTOMYCETE, OF THE SPECIES STREPTOMYCES RIMOSUS.
GB1156390A (en) Polyoxin Antibiotics and process for preparing the same
ES468942A1 (en) Method for producing cepham compounds
US4163051A (en) Streptomycetal antibiotic
GB1356723A (en) Antibiotic sf-1293 substance and its production and uses
ES451318A1 (en) Fermentation of cephamycin C
SU420153A3 (en) METHOD OF ISOLATION AND / OR CLEANING OF CEFAMICINE C
GB757089A (en) Improvements in or relating to antibiotics
JPS57102890A (en) Beta-lactam antibiotic pa-31088-ii and its preparation
Phillips et al. Some 7-Substituted Derivatives of 8-Quinolinol
CA1142468A (en) Antibiotic sf-2050 and sf-2050b substances and production and use thereof